Acorn Bioventures
Overview
Acorn Bioventures invests across stages in small-cap public and private biotechnology companies focused on bringing novel innovative medicines to patients. Our investment flexibility allows us to provide value across the entire specturm forom seeed financing, cross-over financings, IPOs, registered direct offerings, PIPEs, open market purchases, etc. Management teams of our portfolio companies are our long-term partners and we are proud to be part of the entreprenurial spirit and pionerring spirit in biotech.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CG Oncology | Aug 2023 | Crossover Round | Co-investor |
| Bicara Therapeutics | Dec 2023 | Series C | Co-investor |
| OnKure Therapeutics | Oct 2024 | Private Placement | Co-investor |
| Acrivon Therapeutics | Apr 2024 | PIPE | Co-investor |
| Neurosterix | Apr 2024 | Series A | Co-investor |
For institutional investors. Book with your work email.
Key People
Anders Hove
Partner and Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Acorn Bioventures based?
Acorn Bioventures is headquartered in New York City, New York, United States.
When was Acorn Bioventures founded?
Acorn Bioventures was founded in 2017.
How many portfolio companies does Acorn Bioventures have?
Acorn Bioventures has 9 portfolio companies in Caplight's dataset.
What are some companies in Acorn Bioventures's portfolio?
Portfolio companies visible on Caplight include CG Oncology, Bicara Therapeutics, OnKure Therapeutics, Acrivon Therapeutics, Neurosterix.
What was Acorn Bioventures's most recent investment shown here?
Acorn Bioventures's most recent investment in this portfolio sample was in OnKure Therapeutics in 2024.
What sectors does Acorn Bioventures focus on?
Acorn Bioventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Acorn Bioventures focus on?
Acorn Bioventures typically invests at the MultiStage stage.
What is Acorn Bioventures's AUM?
Acorn Bioventures's assets under management are estimated between $250.0M and $500.0M.